Among last week's highlights, Keryx jumps on a solid Phase III trial, Sarepta gets pounded from a fake tweet and Halozyme suffers from analyst downgrades. More
3 Medical Devices Stocks to Sell Now
The ratings of three Medical Devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Investors’ Fear Has All but Vanished
If investors are concerned over the high level of the advance, the VIX is no longer showing it. More
Japan Repeats the Past — Again
Shinzo Abe's new stimulus plan is the same as the country's old stimulus plans -- and it shows Japan hasn't learned any lessons yet. More
15 “Triple F” Stocks to Sell
This week, 15 stocks get F's ("strong strong") in Portfolio Grader's three main grading categories, Total Grade, Overall Fundamental Grade, and Quantitative Grade. More
15 “Triple A” Stocks to Buy
This week, 15 stocks get A's ("strong buy") in Portfolio Grader's three main grading categories, Total Grade, Overall Fundamental Grade, and Quantitative Grade. More
